Antibody surrogates for therapeutics, in vivo imaging,
and in vitro diagnostics

Specific to the chosen epitope of the desired target protein
Pico-molar and low nano-molar binding affinities
Fully synthetic small peptides for rapid and robust manufacturing
Indi Molecular’s CEO, Dr. Albert A. Luderer will speak at Biotech Showcase on January 9, 2019 at the Hilton Union Square, San Francisco, CA. The presentation time is January 9 10:30 AM and it will be held in Franciscan D (Ballroom Level).
CULVER CITY, CA – August 31, 2018 – Indi Molecular, an emerging life sciences company, announced today that it has appointed Joey Mason, M.D., as Board Member.
CULVER CITY, CA – August 22, 2018 – Indi Molecular, an emerging life sciences company, announced today that it has appointed Michael T. Klimas Ph.D. as senior vice president of strategy and technical business development.